Table 4.
Comparison between intramural and intraluminal lipomas of the esophagus
Intramural (n=20) | Intraluminal (n=156) | p | |
---|---|---|---|
Male, n (%) | 14 (70) | 103 (66) | 0.71 |
Age, years, mean (± SD) | 54.7 (± 20.8) | 55.6 (± 15.9) | 0.82 |
Site (%) | |||
Cervical | 9 (47.4) | 141 (90.4) | |
Thoracic | 4 (21.1) | 7 (4.5) | < 0.01 |
Distal | 6 (31.5) | 8 (5.1) | |
Size (± SD) | |||
Length | 9.46 (± 5.5) | 12.5 (± 5.3) | 0.02 |
Width | 4.3 (± 2.1) | 3.8 (± 2.1) | 0.32 |
Duration of symptoms, months (± SD) | 11.6 (± 8.1) | 11.1 (± 9.3) | 0.82 |
Adverse events, n (%) | 2 (10) | 16 (10.2) | 0.97 |
Deaths, n (%) | 0 (0) | 8 (5.2) | 0.30 |
Hospital stay, days, mean (± SD) | 9.2 (± 8.3) | 7.6 (± 6.7) | 0.33 |